Skip to content

Evaluating process and effectiveness of a low-intensity CBT intervention for women with gynaecological cancer (The EPELIT Trial)

 

 

In the UK alone, around 21,500 women are diagnosed with gynaecological cancer each year. More and more women have been surviving gynaecological cancer over the past few decades thanks to the use of early detection tests, such as cervical screening, and improved treatment, such as chemotherapy. However, receiving a cancer diagnosis can have a huge impact on the individual even after the cancer has been treated leaving individuals to deal with common mental health problems such as anxiety and depression.

There are few research studies which look at the impact of gynaecological cancer in women, especially after they have received treatment for their cancer. By conducting research in this area, we can identify the various needs that survivors of gynaecological cancer may have. Previous research has shown that psychological intervention can be helpful for survivors of other types of cancer. Therefore, we are researching whether a psychological intervention is helpful for survivors of gynaecological cancer.

We are using a non-randomised controlled trial design for this pilot study. We have used this type of design as there is already a service in Cambridgeshire that provides a psychological intervention for survivors of gynaecological cancer. We need to compare this group with a group of gynaecological cancer survivors not receiving the intervention in order to see if this intervention might be helpful.

The EPELIT trial is funded by the University of Chester, and ends in 2020.

 

For more information, please contact the Principal Investigator, Prof Nick Hulbert-Williams at n.hulbertwilliams@chester.ac.uk.